نتائج البحث - "Progesterone"

المساهمون: Pizzuti, L, Krasniqi, E, Barchiesi, G, Della Giulia, M, Izzo, F, Sanguineti, G, Marchetti, P, Mazzotta, M, Giusti, R, Botticelli, A, Gamucci, T, Natoli, C, Grassadonia, A, Tinari, N, Iezzi, L, Tomao, S, Tomao, F, Tonini, G, Santini, D, Astone, A, Michelotti, A, De Angelis, C, Mentuccia, L, Vaccaro, A, Magnolfi, E, Gelibter, A, Magri, V, Cortesi, E, D'Onofrio, L, Cassano, A, Rossi, E, Cazzaniga, M, Moscetti, L, Omarini, C, Piacentini, F, Fabbri, M, Scinto, A, Corsi, D, Carbognin, L, Bria, E, La Verde, N, Samaritani, R, Garufi, C, Barni, S, Mirabelli, R, Sarmiento, R, Veltri, E, D'Auria, G, Paris, I, Giotta, F, Lorusso, V, Cardillo, F, Landucci, E, Mauri, M, Ficorella, C, Roselli, M, Adamo, V, Ricciardi, G, Russo, A, Berardi, R, Pistelli, M, Fiorio, E, Cannita, K, Sini, V, D'Ostilio, N, Foglietta, J, Greco, F, Zamagni, C, Garrone, O, Di Cocco, B, Baldini, E, Livi, L, Desideri, I, Meattini, I, Sarobba, G, Del Medico, P, De Tursi, M, Generali, D, De Maria, R, Risi, E, Ciliberto, G, Sperduti, I, Villa, A, Barba, M, Di Leo, A, Vici, P

المصدر: International Journal of Cancer

مصطلحات موضوعية: Oncology, Cancer Research, Multivariate analysis, Settore MED/06 - Oncologia Medica, Receptor, ErbB-2, T-DM1, Estrogen receptor, 0302 clinical medicine, ErbB-2, Trastuzumab, Receptors, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Molecular Targeted Therapy, Neoplasm Metastasis, Cancer Therapy and Prevention, Progesterone, Aged, 80 and over, advanced breast cancer, Tumor, real world, Middle Aged, Prognosis, Metastatic breast cancer, Immunohistochemistry, Gene Expression Regulation, Neoplastic, trastuzumab, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, HER2 positive, pertuzumab, Adult, Aged, Biomarkers, Tumor, Breast Neoplasms, Humans, Neoplasm Staging, Receptors, Progesterone, Pertuzumab, medicine.drug, Receptor, medicine.medical_specialty, T‐DM1, chemotherapy, 03 medical and health sciences, Breast cancer, Settore MED/04 - PATOLOGIA GENERALE, Internal medicine, medicine, Neoplastic, business.industry, medicine.disease, Estrogen, Settore CHIM/08 - Chimica Farmaceutica, Gene Expression Regulation, MED/06 - ONCOLOGIA MEDICA, business, Biomarkers, Hormone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c744e104d7bb709c3f49904f7a5d8b4
http://hdl.handle.net/11573/1307277

6

Role of Melatonin in Breast Carcinoma: Correlation of Expression Patterns of Melatonin-1 Receptor With Estrogen, Progesterone, and HER2 Receptors

المؤلفون: Tulika Gupta, Daisy Sahni, Ruchi Goyal, Gurpreet Singh, Amanjit Bal

المصدر: Applied Immunohistochemistry & Molecular Morphology. 28:518-523

مصطلحات موضوعية: Adult, 0301 basic medicine, Histology, Receptor, ErbB-2, medicine.drug_class, Breast Neoplasms, Triple Negative Breast Neoplasms, Melatonin receptor, Pathology and Forensic Medicine, Melatonin, 03 medical and health sciences, 0302 clinical medicine, Humans, Medicine, Correlation of Data, Receptor, business.industry, Receptor, Melatonin, MT1, Myoepithelial cell, Epithelial Cells, Middle Aged, Immunohistochemistry, Epithelium, Gene Expression Regulation, Neoplastic, Medical Laboratory Technology, Cross-Sectional Studies, Ki-67 Antigen, 030104 developmental biology, medicine.anatomical_structure, Receptors, Estrogen, Estrogen, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Cancer research, Blood Vessels, Female, Receptors, Progesterone, business, Breast carcinoma, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834770f178fe22f5eb6e45fe06589257
https://doi.org/10.1097/pai.0000000000000788

7

Immunohistochemical Evaluation of Ki-67 and Comparison with Clinicopathologic Factors in Breast Carcinomas

المؤلفون: Ahoua Benjamin Effi, Brahima Doukoure, Baumaney Sylvanus Koui, Mohamed Kouyate, Ibrahiman Toure, Zie Cheick Traore, Kouadio Donatien Koffi, Nguiessan Alphonse Aman

المصدر: Asian Pacific Journal of Cancer Prevention : APJCP

مصطلحات موضوعية: Adult, 0301 basic medicine, medicine.medical_specialty, Receptor, ErbB-2, Breast Neoplasms, Gastroenterology, PR, primary breast cancer, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, HER2, Internal medicine, Biomarkers, Tumor, Humans, Medicine, Prospective Studies, Triple negative, Aged, Aged, 80 and over, biology, business.industry, Carcinoma, Ductal, Breast, Mean age, General Medicine, Middle Aged, Prognosis, medicine.disease, Immunohistochemistry, Gene Expression Regulation, Neoplastic, Carcinoma, Lobular, Ki-67 Antigen, 030104 developmental biology, ER, Receptors, Estrogen, 030220 oncology & carcinogenesis, Ki-67, biology.protein, Female, Analysis of variance, Receptors, Progesterone, business, Primary breast cancer, Tamoxifen, Research Article, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3b0402a6eee3dc53602efb84b48beeb
https://doi.org/10.31557/apjcp.2019.20.1.73

8

Breast cancer biomarkers before and after neoadjuvant chemotherapy: does repeat testing impact therapeutic management?

المؤلفون: Debra L. Zynger, Alexander K. Quinones, Gary Tozbikian, Zhaoying Xian

المصدر: Human Pathology. 62:215-221

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Pathology, Time Factors, Receptor, ErbB-2, medicine.medical_treatment, Estrogen receptor, Breast Neoplasms, Triple Negative Breast Neoplasms, Pathology and Forensic Medicine, Tertiary Care Centers, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Predictive Value of Tests, Trastuzumab, Internal medicine, Progesterone receptor, Biopsy, Biomarkers, Tumor, medicine, Humans, Neoplasm Invasiveness, Clinical significance, Practice Patterns, Physicians', skin and connective tissue diseases, Mastectomy, Retrospective Studies, Chemotherapy, medicine.diagnostic_test, business.industry, Biopsy, Needle, Carcinoma, Reproducibility of Results, Middle Aged, medicine.disease, Immunohistochemistry, Neoadjuvant Therapy, Treatment Outcome, 030104 developmental biology, Receptors, Estrogen, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, Receptors, Progesterone, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7474798e3cce4b704eac0b0b09d6d6
https://doi.org/10.1016/j.humpath.2016.12.019

View record from ScienceDirect

Full Text via ClinicalKey

9

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer

المؤلفون: Shen Zhao, Xi Jin, Yi Xiao, Xi Yu Liu, Zhimin Shao, Ding Ma, Yi-Zhou Jiang

المصدر: Theranostics

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.drug_class, Receptor, ErbB-2, Medicine (miscellaneous), Estrogen receptor, Breast Neoplasms, 03 medical and health sciences, Genetic Heterogeneity, 0302 clinical medicine, Breast cancer, Antineoplastic Agents, Immunological, Trastuzumab, Internal medicine, medicine, Humans, skin and connective tissue diseases, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), molecular classification, business.industry, luminal A, Cancer, Middle Aged, medicine.disease, Progesterone Receptor Positive, 030104 developmental biology, Treatment Outcome, Receptors, Estrogen, Estrogen, 030220 oncology & carcinogenesis, triple-positive breast cancer, Cohort, Immunohistochemistry, Female, Tumor Suppressor Protein p53, business, Receptors, Progesterone, multiomics, medicine.drug, Research Paper

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eeb3441dad5231c5a5005e839719010
https://pubmed.ncbi.nlm.nih.gov/31410192

Find this article in full text from ProQuest

10

Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial

المساهمون: Conte, B., Bruzzone, M., Lambertini, M., Poggio, F., Bighin, C., Blondeaux, E., De Laurentiis, M., Valle, E., Cognetti, F., Nistico, C., De Placido, S., Garrone, O., Gamucci, T., Montemurro, F., Puglisi, F., Cardinali, B., Fregatti, P., Miglietta, L., Boccardo, F., Ceppi, M., Del Mastro, L.

المصدر: European journal of cancer (Oxford, England : 1990). 136

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Dose-dense chemotherapy, Receptor, ErbB-2, Luminal subtype, Gastroenterology, Cohort Studies, 0302 clinical medicine, Breast cancer, Antineoplastic Combined Chemotherapy Protocols, Medicine, Hormone receptor-positive, Aged, 80 and over, Hazard ratio, Middle Aged, Prognosis, Immunohistochemistry, Phenotype, Oncology, Receptors, Estrogen, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Cohort, Disease Progression, Female, Receptors, Progesterone, Breast Neoplasm, Epirubicin, medicine.drug, Human, Adult, medicine.medical_specialty, Prognosi, Breast Neoplasms, 03 medical and health sciences, Internal medicine, Adjuvant therapy, Humans, Survival analysis, Cancer staging, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, Dose-Response Relationship, Drug, business.industry, medicine.disease, Survival Analysis, 030104 developmental biology, Cohort Studie, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0bc70e0d1926515cf46f037b16582e3
https://pubmed.ncbi.nlm.nih.gov/32634760

View record from ScienceDirect

Full Text via ClinicalKey

تنقيح النتائج